Aurobindo Pharma informs about press release

22 Nov 2023 Evaluate

Aurobindo Pharma has informed that it enclosed a copy of the Press Release titled ‘Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta™ (Efbemalenograstim alfa Injection) for ChemotherapyInduced Neutropenia (CIN)’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1152.45 0.65 (0.06%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.30
Dr. Reddys Lab 6198.90
Cipla 1402.20
Zydus Lifesciences 957.00
Lupin 1645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.